Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation

Cancer Letters

Volumn 282, Issue 2, 2009, Pages 177-186

  Hypes, Melissa K ^a   Pirisi, Lucia ^a   Creek, Kim E ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

HPV mediated transformation; Human keratinocytes; TGF receptors

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA METHYLATION; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; MOLECULAR PROBE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE; VIRUS ONCOGENE; WESTERN BLOTTING;

BINDING SITES; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA METHYLATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMAN PAPILLOMAVIRUS 16; HUMANS; MUTATION; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPRESSOR PROTEINS; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 67649949491     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.03.014     Document Type: Article

References (35)

1. Huang S.S., and Huang J.S. TGF-β control of cell proliferation. J. Cell. Biochem. 96 (2005) 447-462
2. Massague J., and Gomis R.R. The logic of TGF-β signaling. FEBS Lett. 580 (2006) 2811-2820
3. Rahimi R.A., and Leof E.B. TGF-β signaling: a tale of two responses. J. Cell. Biochem. 102 (2007) 593-608
4. Moustakas A., Pardali K., Gaal A., and Heldin C.H. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 82 (2002) 85-91
5. Mehra A., and Wrana J.L. TGF-beta and the Smad signal transduction pathway. Biochem. Cell. Biol. 80 (2002) 605-622
6. Feng X.-H., and Derynck R. Specificity and versatility in TGF-β signaling through smads. Ann. Rev. Cell Dev. Biol. 21 (2005) 659-693
7. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J., Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16 (1997) 5353-5362
8. Pardali K., and Moustakas A. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 1775 (2007) 21-62
9. Jakowlew S.B. Transforming growth factor-β in cancer and metastasis. Cancer Metast. Rev. 25 (2006) 435-457
10. Creek K.E., Geslani G., Batova A., and Pirisi L. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes. Adv. Exp. Med. Biol. 375 (1995) 117-135
11. Pirisi L., Creek K.E., Doniger J., and DiPaolo J.A. Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis 9 (1988) 1573-1579
12. Creek K.E., Jenkins G.R., Khan M.A., Batova A., Hodam J.R., Tolleson W.H., and Pirisi L. Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes. Adv. Exp. Med. Biol. 354 (1994) 19-35
13. Borger D.R., Mi Y., Geslani G., Zyzak L.L., Batova A., Engin T.S., Pirisi L., and Creek K.E. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta. Virology 270 (2000) 397-407
14. Mi Y., Borger D.R., Fernandes P.R., Pirisi L., and Creek K.E. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression. Virology 270 (2000) 408-416
15. Bloom B.B., Humphries D.E., Kuang P.P., Fine A., and Goldstein R.H. Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: regulation by TGF-β. Biochim. Biophys. Acta 1312 (1996) 243-248
16. Periyasamy S., Ammanamanchi S., Tillekeratne M.P., and Brattain M.G. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Oncogene 19 (2000) 4660-4667
17. Ammanamanchi S., and Brattain M.G. Sp3 is a transcriptional repressor of transforming growth factor-beta receptors. J. Biol. Chem. 276 (2001) 3348-3352
18. Kang S.H., Bang Y.J., Im Y.H., Yang H.K., Lee D.A., Lee H.Y., Lee H.S., Kim N.K., and Kim S.J. Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer. Oncogene 18 (1999) 7280-7286
19. Baldwin A., Pirisi L., and Creek K.E. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression. J. Virol. 78 (2004) 3953-3964
20. Bouwman P., and Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol. Cell. Endocrinol. 195 (2002) 27-38
21. Jackson S.P., MacDonald J.J., Lees-Miller S., and Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63 (1990) 155-165
22. Ammanamanchi S., and Brattain M.G. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3. J. Biol. Chem. 276 (2001) 32854-32859
23. Kang S.H., Won K., Chung H.W., Jong H.S., Song Y.S., Kim S.J., Bang Y.J., and Kim N.K. Genetic integrity of transforming growth factor β (TGF-β) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-β. Int. J. Cancer 77 (1998) 620-625
24. Chen T., de Vries E.G., Hollema H., Yegen H.A., Vellucci V.F., Strickler H.D., Hildesheim A., and Reiss M. Structural alterations of transforming growth factor-β receptor genes in human cervical carcinoma. Int. J. Cancer 82 (1999) 43-51
25. Chu T.Y., Lai J.S., Shen C.Y., Liu H.S., and Chao C.F. Frequent aberration of the transforming growth factor-β receptor II gene in cell lines but no apparent mutation in pre-invasive and invasive carcinomas of the uterine cervix. Int. J. Cancer 80 (1999) 506-510
26. Zhang Q., Rubenstein J.N., Liu V.C., Park I., Jang T., and Lee C. Restoration of expression of transforming growth factor-β type II receptor in murine renal cell carcinoma (renca) cells by 5-aza-2′-deoxycytidine. Life Sci. 76 (2005) 1159-1166
27. Seijo E.R., Song H., Lynch M.A., Jennings R., Qong X., Lazaridis E., Muro-Cacho C., Weghorst C.M., and Munoz-Antonia T. Identification of genetic alterations in the TGFβ type II receptor gene promoter. Mutat. Res. 483 (2001) 19-26
28. Vellucci V.F., and Reiss M. Cloning and genomic organization of the human transforming growth factor-β type I receptor gene. Genomics 46 (1997) 278-283
29. Suske G. The Sp-family of transcription factors. Gene 238 (1999) 291-300
30. Ammanamanchi S., Freeman J.W., and Brattain M.G. Acetylated Sp3 is a transcriptional activator. J. Biol. Chem. 278 (2003) 35775-35780
31. Wang J., Han W., Zborowska E., Liang J., Wang X., Willson J.K.V., Sun L., and Brattain M.G. Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J. Biol. Chem. 271 (1996) 17366-17371
32. Ammanamanchi S., Kim S.-J., Sun L.-Z., and Brattain M.G. Induction of transforming growth factor-β receptor type II expression in estrogen receptor-positive breast cancer cells through Sp1 activation by 5-aza-2′-deoxycytidine. J. Biol. Chem. 273 (1998) 16527-16534
33. Venkatasubbarao K., Ammanamanchi S., Brattain M.G., Mimari D., and Freeman J.W. Reversion of transcriptional repression of Sp1 by 5 aza-2′ deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2. Cancer Res. 61 (2001) 6239-6247
34. Ammanamanchi S., and Brattain M.G. Restoration of transforming growth factor-β signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. J. Biol. Chem. 279 (2004) 32620-32625
35. Thomas M., Narayan N., Pim D., Tomaic V., Massimi P., Nagasaka K., Kranjec C., Gammoh N., and Banks L. Human papillomavirus, cervical cancer and cell polarity. Oncogene 27 (2008) 7018-7030